Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
115.7 USD | +0.46% | -0.93% | -5.30% |
05-31 | Zimmer Biomet's Limited Exposure to High-Growth Markets Spurs Revenue Concerns, UBS Says | MT |
05-31 | Barclays Adjusts Price Target on Zimmer Biomet to $125 From $130 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.30% | 23.69B | |
-6.10% | 178B | |
+0.02% | 107B | |
-1.87% | 67.04B | |
-6.29% | 47.23B | |
+10.91% | 44.62B | |
+9.25% | 42.5B | |
+15.15% | 29.99B | |
+15.97% | 25.22B | |
-5.03% | 24.14B |
- Stock Market
- Equities
- ZBH Stock
- News Zimmer Biomet Holdings, Inc.
- Argus Upgrades Zimmer Biomet to Buy From Hold With $150 Price Target